Format

Send to

Choose Destination
Blood Adv. 2018 Jan 23;2(2):120-125. doi: 10.1182/bloodadvances.2017012682.

Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype.

Author information

1
Fred Hutchinson Cancer Research Center, Seattle, WA.
2
Department of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA.
3
Comprehensive Bone Marrow Failure Center.
4
Department of Pathology and Laboratory Medicine, and.
5
Department of Pulmonary and Critical Care Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
6
Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Maryland Medical Center, Baltimore, MD.
7
Providence Sacred Heart Children's Hospital Genetics Clinic, Spokane, WA.
8
Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan; and.
9
Blood and Marrow Transplant Section, Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
PMID:
29365320
PMCID:
PMC5787871
DOI:
10.1182/bloodadvances.2017012682
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center